XML 15 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Other Intangible Assets Intangible Assets (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 28, 2013
Jun. 28, 2014
Jun. 29, 2013
Jun. 30, 2012
Financial Instruments [Abstract]        
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis  
The following tables summarize the valuation of the Company’s financial instruments carried at fair value by the above pricing categories as of June 28, 2014 and June 29, 2013 (in millions):
 
June 28, 2014
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Investment securities
$
20.7

 
$

 
$

 
$
20.7

Foreign currency forward contracts

 
3.1

 

 
3.1

Funds associated with Israeli post employment benefits

 
19.3

 

 
19.3

Total
$
20.7

 
$
22.4

 
$

 
$
43.1

Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$

 
$

 
$
17.4

 
$
17.4

Interest rate swap agreements

 
8.3

 

 
8.3

Foreign currency forward contracts

 
0.8

 

 
0.8

Total
$

 
$
9.1

 
$
17.4

 
$
26.5

 
June 29, 2013
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Foreign currency forward contracts
$

 
$
8.0

 
$

 
$
8.0

Funds associated with Israeli post-employment benefits

 
16.1

 

 
16.1

Total
$

 
$
24.1

 
$

 
$
24.1

Liabilities:
 
 
 
 
 
 
 
Contingent consideration
$

 
$

 
$
22.2

 
$
22.2

Interest rate swap agreements

 
10.8

 

 
10.8

Foreign currency forward contracts

 
0.4

 

 
0.4

Total
$

 
$
11.2

 
$
22.2

 
$
33.4

   
Rollforward of the Assets Measured at Fair Value Using Unobservable Inputs  
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for years ended June 28, 2014 and June 29, 2013 (in millions).
 
Balance at June 29, 2013
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)
Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss)
Purchases or Additions
Sales
Settlements
Balance at June 28, 2014
Liabilities:
 
 
 
 
 
 
 
Contingent Consideration
$
22.2

$
1.1

$

$
0.8

$

$
(6.7
)
$
17.4

 
Balance at June 30, 2012
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)
Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss)
Purchases or Additions
Sales
Settlements
Balance at June 29, 2013
Assets:
 
 
 
 
 
 
 
Investment securities
$
6.5

$

$
2.2

$

$
(8.6
)
$

$

Liabilities:
 
 
 
 
 
 
 
Contingent Consideration
2.9

(0.9
)

22.2


(2.0
)
22.2

   
Research and development $ 6.0 $ 6.0 $ 9.0 $ 0
Intangible assets subject to amortization, Gross   7,394.1 1,473.7  
Intangible assets subject to amortization, Accumulated Amortization   607.1 316.1  
Intangible assets not subject to amortization   69.7 84.8  
Total other intangible assets   7,463.8 1,558.5  
Amortization of Intangible Assets   281.0 94.0 74.8
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]        
2015   427.0    
2016   438.0    
2017   434.0    
2018   427.0    
2019   416.0    
Thereafter   4,645.0    
Trade names and trademarks [Member]
       
Financial Instruments [Abstract]        
Intangible assets not subject to amortization   59.5 57.0  
In Process Research and Development [Member]
       
Financial Instruments [Abstract]        
Intangible assets not subject to amortization   10.2 27.8  
Distribution And License Agreements [Member]
       
Financial Instruments [Abstract]        
Intangible assets subject to amortization, Gross   6,027.3 192.7  
Intangible assets subject to amortization, Accumulated Amortization   192.1 28.9  
Developed Technology Rights [Member]
       
Financial Instruments [Abstract]        
Intangible assets subject to amortization, Gross   931.7 896.8  
Intangible assets subject to amortization, Accumulated Amortization   302.5 204.6  
Customer Relationships [Member]
       
Financial Instruments [Abstract]        
Intangible assets subject to amortization, Gross   372.0 358.2  
Intangible assets subject to amortization, Accumulated Amortization   97.5 72.4  
Trade names and trademarks [Member]
       
Financial Instruments [Abstract]        
Intangible assets subject to amortization, Gross   47.8 12.7  
Intangible assets subject to amortization, Accumulated Amortization   5.6 4.2  
Noncompete Agreements [Member]
       
Financial Instruments [Abstract]        
Intangible assets subject to amortization, Gross   15.3 13.3  
Intangible assets subject to amortization, Accumulated Amortization   9.4 6.0  
Paddock Laboratories Inc [Member]
       
Financial Instruments [Abstract]        
Reclass of IPR&D to Developed Product Technology   $ 13.0 $ 10.0  
Paddock Laboratories Inc [Member] | Developed Technology Rights [Member]
       
Financial Instruments [Abstract]        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life   12 years 12 years